SEC Form 4 · accession 0001179110-16-025246
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack E Stover
Director
Period of report
May 18, 2016
Accepted (ET)
May 20, 2016 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $0.52 | May 18, 2016 | A | 10,000 | A | — | May 18, 2026 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (right to purchase)F2 | $0.52 | May 18, 2016 | A | 20,000 | A | — | May 18, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1These options vest over one year in 12 equal monthly installments.
- F2These options vest annually over a 3 year-period: 33% on May 18, 2017, 33% on May 18,2018 and 34% on May 18, 2019.